Safety and efficacy of doravirine as first-line therapy in adults with HIV-1: week 192 results from the open-label extensions of the DRIVE-FORWARD and DRIVE-AHEAD phase 3 trials
Chloe Orkin(Queen Mary University of London), Christine Katlama(Université Paris Cité), Pierre‐Marie Girard, Alex Lund Laursen(Aarhus University), Alexander Zoufaly(Kaiser-Franz-Josef-Spital), Sushma Kumar(Merck & Co., Inc., Rahway, NJ, USA (United States)), Peter Sklar(Merck & Co., Inc., Rahway, NJ, USA (United States)), Norma Porteiro, Ernest Asante‐Appiah(Merck & Co., Inc., Rahway, NJ, USA (United States)), Hedy Teppler(Unknown), M. Reyes, Alejandro Afani, Mark Bloch(Epworth Hospital), Khuanchai Supparatpinyo(Chiang Mai University), Valerie Teal(Merck & Co., Inc., Rahway, NJ, USA (United States)), Robert Finlayson, Jean‐Michel Molina(Assistance Publique – Hôpitaux de Paris), Rima Lahoulou(MSD (France)), Pedro Cahn(Hospital San Juan de Dios), Johannes Lombaard, Richard Moore(Leeds Dental Hospital), Gustavo Lopardo, Yazdan Yazdanpanah(Inserm), Havilland Campbell(Merck & Co., Inc., Rahway, NJ, USA (United States)), Graham Smith, Sylvia Hartl, Armin Rieger, Maria Isabel Enriqueta Campos Barker, Hong Wan(Merck & Co., Inc., Rahway, NJ, USA (United States)), Zhi Jin Xu(Merck & Co., Inc., Rahway, NJ, USA (United States)), Brigitte Schmied, Carolina Eugenia Chahin Anania, Brian Conway(University of British Columbia), James McMahon, David Alfred Baker, Marcelo D Martins, Carlos Perez Cortes, Jan Gerstoft, Philippe Morlat, Anita Rachlis(University of Toronto), Norman Roth, François Raffi, Robert Zangerle, Fiona Smaill, Laurence Slama, Sharon Walmsley(University Health Network), Laurent Cotte(San Francisco General Hospital), Nina Weis
Cited by 31
Related Papers
Antiretroviral Treatment of Adult HIV Infection
|JAMA|2012|2.5k
On-Demand Preexposure Prophylaxis in Men at High Risk for HIV-1 Infection
|New England Journal of Medicine|2015|1.6k
Letermovir Prophylaxis for Cytomegalovirus in Hematopoietic-Cell Transplantation
|New England Journal of Medicine|2017|1.2k
Antiretroviral-Drug Resistance among Patients Recently Infected with HIV
|New England Journal of Medicine|2002|1.1k
Effect of Early versus Deferred Antiretroviral Therapy for HIV on Survival
|New England Journal of Medicine|2009|1.1k